• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型和去分化型腹膜后脂肪肉瘤患者的预后和生存情况。

Prognosis and survival of patients diagnosed with well-differentiated and dedifferentiated retroperitoneal liposarcoma.

机构信息

Departamento de Ciencias Morfológicas y Sociosanitarias, Facultad de Medicina y Enfermería, Universidad de Córdoba, Córdoba, Spain.

Servicio de Anatomía Patológica, Hospital Universitario Reina Sofía de Córdoba, Córdoba, Spain.

出版信息

Cir Esp (Engl Ed). 2022 Oct;100(10):622-628. doi: 10.1016/j.cireng.2022.06.034. Epub 2022 Jun 23.

DOI:10.1016/j.cireng.2022.06.034
PMID:35753575
Abstract

OBJECTIVES

The main objective is to establish the overall survival and disease-free survival profiles regarding the patients with retroperitoneal liposarcoma, making a comparison based on the well-differentiated and dedifferentiated histological subtypes. The secondary objectives are to descriptively analyze the clinical characteristics of said patients and to identify and analyze other independent variables that might modify these survival profiles significantly.

METHODS

An observational and analytical study was performed using a retrospective historical cohort that was followed prospectively. The inclusion criteria consisted of: the procedure of liposarcoma located in the retroperitoneum, the well-differentiated and dedifferentiated histological subtypes, between January of 2002 and May of 2019. As a result, 32 patients took part in this study's sample. Kaplan-Meier estimator was used to summarise the results and log-rank test was used in the comparative analysis.

RESULTS

The overall survival at 5 years was around 59%. No differences were found between the patients with a well-differentiated subtype compared to the dedifferentiated ones (p = 0.834). The disease-free survival at 2 years was 59% regarding the well-differentiated and 26% regarding the dedifferentiated, with these differences being statistically significant (p = 0.005). None of the other studied variables modified these survival profiles significantly.

CONCLUSIONS

Dedifferentiated retroperitoneal liposarcomas show less disease-free survival than well-differentiated liposarcomas. However, regarding overall survival no differences can be claimed.

摘要

目的

本研究旨在建立腹膜后脂肪肉瘤患者的总生存和无病生存曲线,并基于高分化和去分化组织学亚型进行比较。次要目标是对这些患者的临床特征进行描述性分析,并确定和分析可能显著改变这些生存曲线的其他独立变量。

方法

本研究采用回顾性历史队列的观察性和分析性研究方法,前瞻性随访。纳入标准为:腹膜后脂肪肉瘤手术、高分化和去分化组织学亚型、2002 年 1 月至 2019 年 5 月。最终,共有 32 名患者纳入本研究样本。采用 Kaplan-Meier 估计法总结结果,采用对数秩检验进行比较分析。

结果

5 年总生存率约为 59%。高分化组与去分化组患者之间无差异(p=0.834)。高分化组和去分化组的 2 年无病生存率分别为 59%和 26%,差异具有统计学意义(p=0.005)。其他研究变量均未显著改变这些生存曲线。

结论

去分化腹膜后脂肪肉瘤的无病生存率低于高分化脂肪肉瘤。然而,在总生存率方面,没有差异。

相似文献

1
Prognosis and survival of patients diagnosed with well-differentiated and dedifferentiated retroperitoneal liposarcoma.分化型和去分化型腹膜后脂肪肉瘤患者的预后和生存情况。
Cir Esp (Engl Ed). 2022 Oct;100(10):622-628. doi: 10.1016/j.cireng.2022.06.034. Epub 2022 Jun 23.
2
Prognosis and survival of patients diagnosed with well-differentiated and dedifferentiated retroperitoneal liposarcoma.高分化和去分化腹膜后脂肪肉瘤患者的预后与生存情况
Cir Esp (Engl Ed). 2021 Aug 5. doi: 10.1016/j.ciresp.2021.06.010.
3
Retroperitoneal and Mesenteric Liposarcomas.腹膜后和肠系膜脂肪肉瘤。
Surg Oncol Clin N Am. 2022 Jul;31(3):399-417. doi: 10.1016/j.soc.2022.03.005.
4
Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.组织学亚型和手术切缘可预测腹膜后脂肪肉瘤的复发模式和生存率。
Ann Surg. 2003 Sep;238(3):358-70; discussion 370-1. doi: 10.1097/01.sla.0000086542.11899.38.
5
Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.腹膜后脂肪肉瘤:对86例脂肪肉瘤和恶性纤维组织细胞瘤进行临床病理复查后对去分化的随访分析
Cancer. 2006 Jun 15;106(12):2725-33. doi: 10.1002/cncr.21933.
6
[An exceptional association between retroperitoneal dedifferentiated liposarcoma and well differentiated pericolonic liposarcoma: about a case].[腹膜后去分化脂肪肉瘤与结肠周围高分化脂肪肉瘤的罕见关联:病例报告]
Pan Afr Med J. 2016 Dec 21;25:254. doi: 10.11604/pamj.2016.25.254.10398. eCollection 2016.
7
[Giant lipomas or retroperitoneal liposarcomas? Controversies in their diagnosis and treatment].[巨大脂肪瘤还是腹膜后脂肪肉瘤?它们诊断与治疗中的争议]
Rev Esp Patol. 2021 Apr-Jun;54(2):75-84. doi: 10.1016/j.patol.2020.06.006. Epub 2020 Jul 25.
8
[Clinico-morphological properties and surgical treatment results in retroperitoneal liposarcomas].[腹膜后脂肪肉瘤的临床形态学特征及外科治疗结果]
Vopr Onkol. 2012;58(1):94-100.
9
Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous components: a case report.伴有骨肉瘤成分的腹膜后去分化脂肪肉瘤:一例报告
Int J Clin Exp Pathol. 2013 Jun 15;6(7):1427-31. Print 2013.
10
Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation.去分化脂肪肉瘤:155例临床病理分析及去分化扩展定义的提议
Am J Surg Pathol. 1997 Mar;21(3):271-81. doi: 10.1097/00000478-199703000-00002.

引用本文的文献

1
Challenges and hope: latest research trends in the clinical treatment and prognosis of liposarcoma.挑战与希望:脂肪肉瘤临床治疗与预后的最新研究趋势
Front Pharmacol. 2025 May 12;16:1529755. doi: 10.3389/fphar.2025.1529755. eCollection 2025.
2
"Enhancing Liposarcoma Prognosis - A New Predictive Scoring System Integrating Histopathological Insights".提高脂肪肉瘤预后——一种整合组织病理学见解的新预测评分系统
Cancer Manag Res. 2025 Feb 17;17:331-348. doi: 10.2147/CMAR.S504889. eCollection 2025.
3
Retroperitoneal Soft Tissue Sarcoma and Kidney Autotransplantation: A Case Report.
腹膜后软组织肉瘤与自体肾移植:一例报告
Clin Case Rep. 2025 Jan 12;13(1):e9681. doi: 10.1002/ccr3.9681. eCollection 2025 Jan.
4
Oncogenic Functions of Alternatively Spliced Isoform in Retroperitoneal Liposarcoma.剪接异构体在腹膜后脂肪肉瘤中的致癌功能
Int J Mol Sci. 2024 Dec 17;25(24):13516. doi: 10.3390/ijms252413516.
5
R0 surgical resection of giant dedifferentiated retroperitoneal liposarcomas in the COVID era with and without nephrectomy: A case report.COVID 疫情时代巨大去分化型腹膜后脂肪肉瘤伴或不伴肾切除术的 R0 手术切除:1 例病例报告
Oncol Lett. 2023 Aug 4;26(3):410. doi: 10.3892/ol.2023.13996. eCollection 2023 Sep.
6
Bioinformatics Screen Reveals Gli-Mediated Hedgehog Signaling as an Associated Pathway to Poor Immune Infiltration of Dedifferentiated Liposarcoma.生物信息学筛选揭示Gli介导的Hedgehog信号通路是去分化脂肪肉瘤免疫浸润不良的相关通路。
Cancers (Basel). 2023 Jun 27;15(13):3360. doi: 10.3390/cancers15133360.
7
Development and Validation of a Prognostic Model to Predict the Prognosis of Patients With Retroperitoneal Liposarcoma: A Large International Population-Based Cohort Study.预测腹膜后脂肪肉瘤患者预后的预后模型的开发与验证:一项基于国际大人群的队列研究
Front Oncol. 2022 Jun 2;12:857827. doi: 10.3389/fonc.2022.857827. eCollection 2022.